☰

Regulatory decisions that keep pace with your innovation

For medtech and digital health teams that need to break through the regulatory complexity holding back their time-to-market. 

Get started for free

Inside many medtech companies, product development moves quickly while regulatory answers arrive slowly, inconsistently, and only after significant time and cost have already been spent.

Behind these delays the patients you are on a mission to help are waiting longer for access to safe and effective innovation.

Sounds familiar?

Speed mismatch

Your products move fast. Your regulatory process does not.

Manual overload

RA and QA spend hours searching, cross-checking, and summarizing regulatory content.

Waiting loops

Teams wait days or weeks for answers on classification and regulatory pathways.

Shifting assumptions

Early product decisions rely on assumptions that change after deeper regulatory review.

Inconsistent checks

Pre-submission reviews vary by reviewer, product, and timing.

Costly fallback

External consultants are expensive and rarely available when timelines tighten.

Unpredictable outcome

Slow decisions, late surprises, and senior experts stuck in PDFs instead of moving products and trials forward.

Guideways automates the most time-consuming regulatory tasks around classification, pathways, requirements, and compliance reviews. Your team stays in control of decisions, but the search and review processes now happen in the background. 

Learn more

AI agents purpose-built for regulatory approval and compliance

Guideways acts as your regulatory guide, giving you expert-level insight the moment you describe your product. Guideways focuses on the steps where you lose the most time and certainty: planning, internal alignment, and submission preparation.

Sherpa

Understand your path early

Turn a device description into clear classification options and likely regulatory pathways, identify relevant predicates along with key regulations and guidances, and use this insight to plan clinical and development strategy based on evidence rather than guesswork.

Reviewer

Find gaps before regulators do

Map documents against identified requirements, flag missing sections, inconsistencies, and weak support, and get a structured submission readiness view with clear, prioritized actions.

Researcher

Stronger answers, fewer document deep-dives

Regulatory research tuned to medtech questions, delivering results pulled from regulations, guidances, standards, and approvals, with structured answers and linked references you can use directly in memos, risk assessments, and justifications.

Guideways supports the points where regulatory work slows teams down

Intake and early discussion for new devices

Internal pre-submission reviews and sign-off

Cross-functional meetings around regulatory strategy

Ongoing questions from R&D and clinical teams

Outputs can be exported and attached to the systems you already use. RA/QA stays in charge of interpretation and decisions. Guideways makes the underlying analysis more consistent, traceable, and easier to explain.

“Guideways made it easy and accessible for us to quickly assess where we stand and how to proceed.”

What you get back in time and control? 

Get a faster path from device idea to a realistic regulatory route, avoid late-stage surprises in requirements and documentation, and make better use of limited RA/QA capacity across projects. You’ll also have clearer documentation of regulatory reasoning for audits and internal reviews, and rely less on consultants for repeatable work so you can use them where they add the most value. If this sounds familiar, we can show the full workflow on one of your devices in a live demo.

We can show the full workflow on one of your devices in a live demo.

Get a demo